You’ve probably seen headlines claiming THCP is “33 times stronger than THC.” Sounds wild, right? But the truth is a bit more nuanced — and a lot more interesting.
THCP (tetrahydrocannabiphorol) was discovered by Italian researchers in 2019. It’s not just another cannabinoid — it challenges our understanding of potency, receptor binding, and how even trace compounds might have outsized effects. That said, most of what we know comes from animal studies or early lab work, and the human data is extremely limited. Plus, the legal status is still fuzzy.
The Science Behind THCP
Researchers at the University of Modena were analyzing medical cannabis when they found a previously unknown cannabinoid with a seven-carbon side chain instead of THC’s five. They named it Δ⁹-THCP.
Here’s why that extra carbon chain matters:
- Stronger receptor binding: THCP binds to CB1 receptors with a K_i of ~1.2 nM versus THC’s ~40 nM — roughly 33× stronger.
- Effects in animals: In mice, THCP produces cannabinoid effects (reduced movement, pain relief, lower body temperature) at lower doses than THC.
- Extremely low natural abundance: THCP occurs in natural cannabis at just 0.0023–0.0136% by dry weight, so standard testing often misses it.
Even tiny amounts might contribute to how certain strains feel, especially in combination with THC, CBD, and terpenes.
How THCP Differs from THC and Other Cannabinoids
“33× stronger” sounds scary, but that’s just binding affinity — it doesn’t mean you’ll feel 33 times higher. Real-world potency is more like twice as strong as THC based on animal studies.
Other key differences:
- Partial vs. full agonist: THC partially activates CB1 receptors, like a dimmer switch. THCP may act more like a full agonist, pushing the receptor harder — which could explain both its potency and potential risks.
- CB2 binding: THCP binds CB2 receptors (immune cells) 5–10× more strongly than THC, suggesting possible anti-inflammatory effects.
- Side chain comparisons: Other cannabinoids tweak this side chain too — THCV (3 carbons) sometimes blocks THC, THCB (4 carbons) is mildly psychoactive, but THCP (7 carbons) seems to hit a sweet spot for high activity.
So THCP isn’t just “super THC.” It’s chemically distinct with different implications for potency and safety.
Potential Benefits (and Speculative Uses)
We don’t have human clinical trials yet. Everything is inferred from mice or receptor studies:
- Pain relief: In mouse hot-plate tests, THCP increased pain tolerance at lower doses than THC.
- Anti-inflammatory potential: Stronger CB2 binding could mean theoretical benefits for inflammation or autoimmune conditions.
- Sedation/sleep aid: Early reports suggest it might be stronger than THC in promoting relaxation or sleep.
- Other theoretical uses: Appetite, nausea, and anxiety could respond similarly to THC but potentially at lower doses.
⚠️ Cautionary note: there’s a 2025 case report of a person consuming 8 mg of THCP via gummy and experiencing 48 hours of acute psychosis, including suicidal ideation.
How THCP Interacts with the Endocannabinoid System
The ECS keeps mood, pain, appetite, and immunity in balance. Its two main receptors:
- CB1: Mostly in brain and nerves
- CB2: Mostly on immune cells
THCP’s seven-carbon tail lets it fit snugly into CB1 receptors, activating stronger downstream signaling than THC. At CB2, it may influence inflammation more than THC. Even tiny amounts in a strain could subtly modify how the full spectrum of cannabinoids and terpenes affect the user — a kind of “silent moderator” role in the entourage effect.
What Research Exists (and What’s Missing)
We have:
- The 2019 Italian discovery paper detailing THCP isolation and mouse studies
- Lab analyses quantifying THCP in cannabis and showing mislabeling in commercial products
- 2025 case report of psychosis
- Broader cannabis literature linking high-potency use to first-episode psychosis
- Synthetic cannabinoid studies suggesting strong full agonists carry risk
We don’t have:
- Human clinical trials
- Pharmacokinetic or metabolism studies
- Dose-ranging safety trials
- Long-term side-effect profiles
- Standardized purity and quality control
In short: signals exist, but the map is missing.
Legal Status: A Mess in Progress
- Federal (U.S.): The 2018 Farm Bill allows hemp-derived cannabinoids under 0.3% Δ⁹-THC, which some argue includes THCP.
- DEA ambiguity: Synthetic THCP might be classified as a controlled substance.
- State laws: Some states explicitly ban THCP (Colorado, New York, Washington, etc.), while others allow it under hemp rules.
- Potential 2025 changes: Proposed amendments could restrict “synthetically derived” cannabinoids, effectively banning most THCP products.
Always check local laws before buying or using THCP.
Consumption Methods & Risks
- Vaping: Fast onset, dose control possible, but unknown lung effects. Most vapes use 70–85% THCP distillate.
- Edibles: Slow onset (30 min–2 hr), long duration. Overconsumption is common; the psychosis case involved an edible.
- Tinctures: Sublingual dosing (15–45 min onset) allows more control.
- “THCP flower”: Usually hemp sprayed with THCP distillate. Base flower has negligible THCP.
Labels can be misleading, and products are largely unregulated. Exercise extreme caution.
Safety, Side Effects & Unknown Dangers
- THC-like effects (dry mouth, dizziness, anxiety) — potentially stronger and less predictable
- Full agonist risk: psychosis, paranoia, cardiovascular stress at lower doses
- Documented psychosis case at 8 mg THCP
- Synthetic cannabinoid analog risks: agitation, seizures, kidney/cardiac issues
- Unregulated production: contaminants, solvent residues, unknown isomers
- Fails standard THC drug tests
- Potential interactions with medications metabolized in the liver
People with heart conditions, psychiatric history, or substance sensitivity are especially vulnerable.
The Future of THCP in Cannabis & Medicine
THCP is tantalizing, risky, and mysterious:
- Regulation may restrict or eliminate THCP from shelves
- State-level bans may increase as adverse events accumulate
- Research is urgently needed: Phase I safety trials, pharmacokinetics, efficacy studies, and long-term observation
- Manufacturers should adopt transparency, purity testing, and conservative dosing before regulators step in
- THCP could help explain why some strains feel “stronger than THC,” but misuse risk is real
For now, THCP belongs in the curiosity category — not “must try.”
Grow Guide Resources for Cannabis Enthusiasts
Even if THCP fascinates you, start with the basics: healthy plants, proper harvest, and careful curing. Check out our guides:
- Growing cannabis indoors
- Harvest timing for peak potency
- Proper drying and curing techniques
- Plant health diagnostics
High-quality cannabis starts with the plant — whether your interest is THCA, THC, CBD, or THCP.
Meta Description:
FAQ
What makes THCP more potent than THC?
Its seven-carbon alkyl side chain binds more strongly to CB1 receptors than THC’s five-carbon chain, but real-world psychoactive effects appear roughly twice as strong, not 33×.
Is THCP legal in my state?
THCP exists in a gray area. Federally, hemp-derived THCP might be allowed under the 2018 Farm Bill, but at least 14 states explicitly ban it. Check local laws.
How is THCP made?
Naturally occurring THCP is extremely rare (0.0023–0.0136%). Commercial products usually convert CBD chemically into THCP, extending the side chain from five to seven carbons.